Delivery Order SPE2DB20D6035-SPE2DB24FLXJZ
Award Date
9/26/24
Potential Completion Date
9/27/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a medication, with a ceiling value of $8,580.26 and a period of performance through June 27, 2025. This is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HEMABATE 250 MCG/ML AMPULML, a medical product, with a ceiling value of $1,271.85 and a performance period ending on June 27, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HEMABATE 250 MCG/ML AMPULML medical products. The contract has a ceiling value of $3,567.20 and an ultimate completion date of June 11, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,180.16, is for the supply of HEMABATE 250 MCG/ML AMPULML, a specialty medication. The delivery order has a firm fixed-price pricing type and an ultimate completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a ceiling value of $2,543.70 and a firm fixed price pricing type. The contract is for HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, with a period of performance through June 6, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a $10,661.67 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a prescription medication. The contract has a period of performance through February 14, 2023 and is not set aside for any special business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hemabate 250 mcg/mL ampules. The contract has a ceiling value of $1,811.65 and a completion date of September 13, 2023. It is a firm-fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., the parent company, which holds a significant Indefinite...
This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024 with a ceiling value of $4,586.44. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 9, 2024. This award is not designated as a set-aside...
This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm-fixed-price delivery order with a ceiling value of $2,054.69 and a period of performance ending on May 29, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,586.36 firm fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, with an ultimate completion date of October 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...